Cargando…

Editorial: The use of real world data for regulatory purposes in the rare diseases setting

Detalles Bibliográficos
Autores principales:	Giannuzzi, Viviana, Stoyanova-Beninska, Violeta, Hivert, Virginie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730868/ https://www.ncbi.nlm.nih.gov/pubmed/36506540 http://dx.doi.org/10.3389/fphar.2022.1089033

Ejemplares similares

Editorial: Reviews in: regulatory science
por: Kerpel-Fronius, Sandor, et al.
Publicado: (2023)

Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts
por: Maison, Patrick, et al.
Publicado: (2022)

Oncologic orphan drugs approved in the EU – do clinical trial data correspond with real-world effectiveness?
por: Schuller, Yvonne, et al.
Publicado: (2018)

Editorial: Big Data, Pharmacogenomics and Real-World Research in Pharmacology
por: Wei, James Cheng-Chung, et al.
Publicado: (2020)

Regulatory Standards in Orphan Medicinal Product Designation in the EU
por: Tsigkos, Stelios, et al.
Publicado: (2021)

Using real-world data for supporting regulatory decision making: Comparison of cardiovascular and safety outcomes of an empagliflozin randomized clinical trial versus real-world data
por: Jang, Ha Young, et al.
Publicado: (2022)

Haemophilia, state of the art and new therapeutic opportunities, a regulatory perspective
por: Tomeo, Francesca, et al.
Publicado: (2021)

Editorial: Real-world experience with CFTR modulator therapy
por: Tümmler, Burkhard, et al.
Publicado: (2023)

Editorial: Drug re-purposing for the treatment of bacterial infections
por: Tomás, María, et al.
Publicado: (2022)

Considerations in characterizing real‐world data relevance and quality for regulatory purposes: A commentary
por: Girman, Cynthia J., et al.
Publicado: (2018)

Advanced Therapy Medicinal Products for Rare Diseases: State of Play of Incentives Supporting Development in Europe
por: Farkas, Andreas M., et al.
Publicado: (2017)

Outcomes and Incidence of PF-ILD According to Different Definitions in a Real-World Setting
por: Torrisi, Sebastiano Emanuele, et al.
Publicado: (2021)

Drug utilization research in Peru: Is real-world data available?
por: Rodríguez-Tanta, L. Yesenia, et al.
Publicado: (2023)

Real-World Data and Budget Impact Analysis (BIA): Evaluation of a Targeted Next-Generation Sequencing Diagnostic Approach in Two Orthopedic Rare Diseases
por: Pedrini, Elena, et al.
Publicado: (2022)

Real World Data in Health Technology Assessment of Complex Health Technologies
por: Hogervorst, Milou A., et al.
Publicado: (2022)

Effect of Gene-Based Warfarin Dosing on Anticoagulation Control and Clinical Events in a Real-World Setting
por: Zhang, Jinhua, et al.
Publicado: (2020)

Advancing evidence-based treatment of infectious diseases in children with real-world data: Opportunities and challenges
por: Radtke, Kendra K., et al.
Publicado: (2023)

A Comparison of Post-marketing Measures Imposed by Regulatory Agencies to Confirm the Tissue-Agnostic Approach
por: Mulder, Jorn, et al.
Publicado: (2022)

Editorial: Pharmacology of infectious diseases: world tuberculosis day 2022
por: Srivastava, Shashikant, et al.
Publicado: (2023)

Real-world use of orphan medicinal products (OMPs) in rare disease (RD) patients: A population-based registry study
por: Mazzucato, Monica, et al.
Publicado: (2022)

Editorial: Drug development of herbal medicines: Regulatory perspectives
por: Bilia, Anna Rita, et al.
Publicado: (2022)

Considerations when evaluating real‐world data quality in the context of fitness for purpose
por: Reynolds, Matthew W., et al.
Publicado: (2020)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System
por: Jang, Suk-Chan, et al.
Publicado: (2022)

Approach to machine learning for extraction of real-world data variables from electronic health records
por: Adamson, Blythe, et al.
Publicado: (2023)

Editorial: Advancing Genomics for Rare Disease Diagnosis and Therapy Development
por: Liu, Zhichao, et al.
Publicado: (2020)

Comparison of Adverse Kidney Outcomes With Empagliflozin and Linagliptin Use in Patients With Type 2 Diabetic Patients in a Real-World Setting
por: Lee, Yueh-Ting, et al.
Publicado: (2021)

Editorial: Prevention, diagnosis and treatment of rare disorders
por: Cox, Timothy M., et al.
Publicado: (2022)

Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis
por: Lu, Z. Kevin, et al.
Publicado: (2021)

Kidney Injury Following Ibuprofen and Acetaminophen: A Real-World Analysis of Post-Marketing Surveillance Data
por: Shao, Qi-hui, et al.
Publicado: (2021)

Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World Data
por: Lei, Yanna, et al.
Publicado: (2022)

A real-world disproportionality analysis of apalutamide: data mining of the FDA adverse event reporting system
por: Fang, Zhihong, et al.
Publicado: (2023)

Access to medicines for rare diseases: A European regulatory roadmap for academia
por: Rosenberg, Noa, et al.
Publicado: (2023)

Editorial: Overcoming the Challenges of Herbal Adulteration in a Globalized World
por: Booker, Anthony
Publicado: (2021)

Landscape analysis for a neonatal disease progression model of bronchopulmonary dysplasia: Leveraging clinical trial experience and real-world data
por: Barrett, Jeffrey S., et al.
Publicado: (2022)

Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study
por: Zhang, Qiongwen, et al.
Publicado: (2023)

Corrigendum: Big Data and Real-World Data Based Cost-Effectiveness Studies and Decision-Making Models: A Systematic Review and Analysis
por: Lu, Z. Kevin, et al.
Publicado: (2022)

Rare diseases research in Europe: an overview based on data from the Orphanet database
por: Martin, Natalia, et al.
Publicado: (2010)

Oral Anticoagulants Initiation in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort
por: Rodríguez-Bernal, Clara L., et al.
Publicado: (2017)

Stevens-Johnson Syndrome Following Vancomycin and Linezolid: A Real-World Analysis of Post-Marketing Surveillance Data
por: Ni, Ming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f6tib7p52k38bt0gnjm18o3doa